FDA approval

Cop 1 (Copaxone®): The Story of a Drug

Cop 1 (Copaxone®): The Story of a Drug

01.05.1997

Disease, Drugs & Diagnostics

Nearly three decades after a surprising discovery, Copaxone® gets FDA approval for the treatment of MS

New Drug for Multiple Sclerosis Approved by the U.S. Food and Drug Administration

New Drug for Multiple Sclerosis Approved by the U.S. Food and Drug Administration

23.12.1996

Disease, Drugs & Diagnostics

REHOVOT, Israel -- December 23, 1996 -- The U.S. Food and Drug Administration today announced the approval of the Israeli...

New Drug for Multiple Sclerosis Receives Recommendation of a U.S. Food And Drug Administration Advisory Committee

New Drug for Multiple Sclerosis Receives Recommendation of a U.S. Food And Drug Administration Advisory Committee

19.09.1996

Disease, Drugs & Diagnostics

REHOVOT, Israel -- September 19, 1996 -- An advisory committee convened by the U.S. Food and Drug Administration...

Top Stories

Shedding Light on the Dark Hours

Credit: Coleen Murphy, Princeton University, Princeton, NJ

Cracking the Code of a Worm's Throat

“Eight Shining Examples of Excellence”

Burning Cancer’s Bridges

Press Releases

“Eight Shining Examples of Excellence”

The Weizmann Institute of Science Ranked among the World’s Top Ten Academic Institutions

A Discovery to Set Your Heart a-Knocking

Most Popular Articles

The Limits of Computing

Computers can solve complex problems but they are far from omnipotent. Prof. Ran Raz of the Weizmann Institute's Computer Science and Applied Mathematics Department is trying to portray the limits...

One Protein, Two Programs

A cell’s decision to commit suicide involves an exchange of information between two suicide mechanisms

The Coin Toss Paradox

Can a game with “quantum” rules beat the odds?